Our findings provide genetic evidence that TPC2 behaves differently in various stages/types of cancer and indicates that TPC2 gain of function can contribute to tumorigenesis but may hinder metastasis, which warrants further investigations at a molecular level. Here, TPCN2 is linked to cancer.